The information and documents included in this section relate to Icade Santé, a subsidiary of Icade held at 56.84%. Icade Santé’s bonds are admitted to trading on the regulated market of Euronext Paris. These information and documents do not constitute an offer or solicitation to purchase securities in any jurisdiction. The Icade Santé securities have not been offered to the public. The information below do not constitute an offer of Icade Santé securities in the United States.

Contacts

Anne-Sophie Lanaute

Head of financial communication and investor relations

Jean-Philippe Carrascosa

Financing and corporate oversight Director